Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Director departure
CLOVER HEALTH INVESTMENTS, CORP. (CLOV)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/08/2023
10-Q
Quarterly Report for the period ended June 30, 2023
08/08/2023
8-K
Quarterly results
Docs:
"
Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2%, bringing first half MCR to 81.9%
"
08/03/2023
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
"
08/03/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/21/2023
DEF 14A
Form DEF 14A - Other definitive proxy statements:
07/21/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/07/2023
SC 13G/A
BlackRock Inc. reports a 2% stake in CLOVER HEALTH INVESTMENTS CORP CLA
06/30/2023
PRE 14A
Form PRE 14A - Other preliminary proxy statements:
06/08/2023
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
06/08/2023
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/09/2023
10-Q
Quarterly Report for the period ended March 31, 2023
05/09/2023
8-K
Quarterly results
Docs:
"
Clover Health Reports First Quarter 2023 Financial Results Insurance revenue grew by 14% over Q1’22
"
04/26/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023
DEF 14A
Form DEF 14A - Other definitive proxy statements:
04/26/2023
ARS
Form ARS - Annual Report to Security Holders:
04/24/2023
8-K
Quarterly results
04/21/2023
8-K
Quarterly results
04/20/2023
8-K
Quarterly results
03/17/2023
8-K
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data
Docs:
"
BOARD OBSERVER AGREEMENT
"
03/09/2023
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans:
03/01/2023
10-K
Annual Report for the period ended December 31, 2022
02/28/2023
8-K
Quarterly results
Docs:
"
Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results Q4 2022 Insurance MCR of 92.4% and FY 2022 Insurance MCR of 91.8%
"
02/09/2023
SC 13G/A
VANGUARD GROUP INC reports a 8.4% stake in Clover Health Investments Corp. Class A
02/03/2023
SC 13G
BlackRock Inc. reports a 7.1% stake in CLOVER HEALTH INVESTMENTS CORP CLA
02/02/2023
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events Interactive Data
01/20/2023
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2023
8-K
Investor presentation
Docs:
"
Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023 FRANKLIN, Tenn.
",
"
5 2 4 3
"
11/30/2022
8-K
Quarterly results
11/07/2022
10-Q
Quarterly Report for the period ended September 30, 2022
11/07/2022
8-K
Quarterly results
Docs:
"
Clover Health Reports Third Quarter 2022 Financial Results Third quarter Insurance MCR of 86.3% and year-to-date Insurance MCR of 91.7% demonstrate positive momentum
"
09/23/2022
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
09/02/2022
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/12/2022
DEF 14A
Form DEF 14A - Other definitive proxy statements:
08/10/2022
8-K
Quarterly results
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy